Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "undemanding"


25 mentions found


Goldman Sachs reiterates Nvidia as buy Goldman said it sees a "favorable" risk/reward for shares of Nvidia. Goldman Sachs reiterates ServiceNow as buy Goldman said it's standing by its buy rating on the stock following its financial analyst day. Bank of America reiterates Palantir as buy Bank of America said it's sticking with its buy rating after the company released earnings on Monday. Wells Fargo reiterates Goldman Sachs as overweight Wells increased its price target on Goldman to $504 per share from $450. price target."
Persons: TGT, Goldman Sachs, Goldman, ServiceNow, Wells, Palantir, Wolfe, TD Cowen, Ares, Cowen Organizations: Citi, Target, Nvidia, UBS, Vale, Bank of America, Apple, UL, tailwinds, Artificial Intelligence, Nike, Cameco, Nike Inc, Barclays, CVS Locations: Las Vegas
The earnings season is winding down, but there are some names slated to report that could see big moves — in either direction. Already, more than 80% of companies in the S & P 500 have already posted quarterly results this earnings season as of Monday morning. Against that backdrop, CNBC Pro screened for names reporting this week — with market caps of $1 billion or more — that could experience sharp up- or downside moves, based on trading activity in the options market. Here are the names that made the list: Upstart Holdings is the reporter this week that could be in for the biggest move at nearly 19%. Rideshare stock Lyft also made the list.
Persons: Uber, America's Mihir Bhatia, Bhatia, Lyft, LSEG, Jefferies, John Colantuoni, Colantuoni, Bank of America's Jessica Reif Ehrlich, Ehrlich, WBD Organizations: Disney, CNBC Pro, Holdings, LSEG, Bank, America's, Warner Bros, Bank of America's Locations: California
Here are Tuesday's biggest calls on Wall Street: Loop initiates MongoDB as buy Loop sees growth accelerating for the developer data platform company. JPM reiterates General Motors and Ford as overweight JPMorgan said the stocks will benefit from "lower commodities & higher production outside China." JPMorgan upgrades Assai to overweight from neutral JPMorgan said it sees improving trends and better visibility for the Brazilian wholesaler. JPMorgan upgrades Roblox to overweight from neutral JPMorgan said it sees a "compelling entry point" for the stock. JPMorgan downgrades Five Below to neutral from overweight JPMorgan downgraded Five Below due to "ongoing macro pressure."
Persons: JPM, JPMorgan, KeyBanc, Wells, D.A, Davidson, Davidson's, Berenberg, Morgan Stanley, Harley, Evercore, it's bullish, it's, Tesla, Rosenblatt, Oppenheimer, Dwight, Key, Truist, Wolfe, Warner, Price Organizations: Motors, Ford, GM, Nvidia, MU, BMO, prem, NICE, JPMorgan, Barclays, Apple, Albertsons, Catalyst Watch, NOVA, Penn Entertainment, PENN, ESPN Bet, Benchmark, Qualcomm, Warner Brothers, Warner, HBO Locations: China, Texas, U.S
Meta Platforms will report its first-quarter earnings on Wednesday after the closing bell. Wall Street is optimistic about the social media firm's result, citing optimism around AI and ad spending. Here's what Wall Street expects from Meta's first-quarter earnings after the closing bell on Wednesday:Wells Fargo: In need of a new catalystWells Fargo has projected ad-led strength in the first-quarter, with Meta benefiting from a robust e-commerce environment. The bank highlighted the fact that Instagram Reels has reached revenue neutrality, and should remain a key revenue growth tailwind over the coming years. JPMorgan rates Meta at "Overweight" with a $535 price target.
Persons: , Wells, Ken Gawrelski, optionality, Brad Erickson, Goldman Sachs, Goldman, Justin Post, Nitin Bansal, Doug Anmuth Organizations: Service, Meta, RBC, Bank of America, Washington . Bank of America, JPMorgan Locations: Meta's, Fargo, Wells, Washington .
Ultragenyx Pharmaceutical has several growth opportunities ahead that could lead its share price to boom over the next year, according to RBC Capital Markets. Analyst Luca Issi initiated research coverage of the pharmaceutical company, which develops treatments for rare and ultra-rare diseases, with an outperform rating and $77 price target. Ultragenyx is forecasting between $500 million and $530 million in revenue for 2024, driven by rare bone disease drug Crysvita, long-chain fatty acid oxidation disorder drug Dojolvi, as well as therapies Mepsevii and Evkeeza. The analyst is also looking ahead to Ultragenyx's treatments for Angelman syndrome, Glycogen storage disease type 1, or GSD1a, plus Wilson's disease as potential opportunities to drive up the stock. Wilson's disease is a rare genetic disorder that prevents the body from eliminating copper, which then leads it to accumulate in the liver, brain and other organs.
Persons: Luca Issi, Issi, Issi's, Issa, GSD1a Organizations: Ultragenyx Pharmaceutical, RBC Capital Markets, U.S . Food, Drug Administration
Morgan Stanley reiterates Apple as overweight Morgan Stanley lowered its price target on the stock to $210 per share from $220 but says it's sticking with Apple. Bank of America reiterates Amazon as buy Bank of America said it's bullish heading into Amazon earnings next week. Bank of America reiterates Tesla as neutral Bank of America said it's sticking with its neutral rating on Tesla shares. Morgan Stanley upgrades Alcoa to equal weight from underweight Morgan Stanley said it sees a more balanced risk/reward for shares of Alcoa. Bank of America reiterates Apple as buy Bank of America says Apple is a top pick at the firm.
Persons: Goldman Sachs, Goldman, Morgan Stanley, it's, Piper Sandler, Piper, Apple, Q, Q revs, Papa, Stifel, Papa John's, Jefferies, Mizuho, JPMorgan, Raymond James downgrades, Raymond James, TD Cowen, BRBR, BMO downgrades, Tesla, Oppenheimer Organizations: Nvidia, NVIDIA, RBC, Apple, Microsoft, Meta, Bank of America, JPMorgan, Cisco, Deutsche Bank, Realty Trust, Deutsche, Brands, BMO, of America, Alcoa, Kymera Therapeutics, " Bank of America Locations: Singapore, Asia, Brazil
I travel by air every couple of months, and always think about a single, burning question: What makes for a great airplane movie? Not movies about being on planes. “The Ministry of Ungentlemanly Warfare,” the latest offering from the director Guy Ritchie, is a perfect airplane movie. But you’ve got to watch something, and for that, we have movies like this one. Ritchie didn’t always make airplane movies.
Persons: Guy Ritchie, shouldn’t, you’ve, Ritchie didn’t, , Guy Ritchie’s Organizations: Ungentlemanly
Adjusted operating margin expanded to 31.4% in the quarter, missing estimates of 31.55%, according to FactSet. No, but it was an overall solid quarter for Salesforce, with the company beating on most key metrics. In its fiscal 2024, Salesforce repurchased $7.7 billion worth of stock, lowering its diluted share count by about 1 million to 983 million. For the first quarter, Salesforce guided for revenues between $9.12 and $9.17 billion, in line with estimates of $9.15 billion. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: Salesforce, We're, it's, Wednesday's, Marc Benioff, we'd, Amy Weaver, Benioff, Einstein, Cash, Salesforce's, Jim Cramer's, Jim Cramer, Jim, Justin Sullivan Organizations: Revenue, LSEG, Club, CNBC Locations: Americas, Africa, Asia, Latin America, India, Canada, San Francisco , California
Morgan Stanley reiterates Target at overweight Morgan Stanley stood by its overweight rating on the department store owner. Morgan Stanley reiterates Salesforce as overweight Morgan Stanley said it likes the setup heading into earnings later this week. Morgan Stanley upgrades HashiCorp to overweight from equal weight Morgan Stanley said the software company has a compelling valuation. Morgan Stanley upgrades AvalonBay to overweight from equal weight Morgan Stanley said apartment REIT stocks like AvalonBay are '"cheap for a reason." Morgan Stanley upgrades Sun Country to overweight from equal weight Morgan Stanley said it likes the airline's business model.
Persons: Goldman Sachs, Goldman, Morgan Stanley, Salesforce, Rosenblatt, Jefferies, Amer, Wells, Jane Fraser, Roth MKM, Roth, TD Cowen, TD, DA Davidson, OW, Fannie Mae, KBW, Freddie, Truist, it's, Piper Sandler, Piper, Bentley Organizations: Nvidia, BMO, Apollo, Amer Sports, Citi, Citigroup, Bank of America, KKR, APO, BJ's Wholesale, D.A, Susquehanna, Energy, HSBC downgrades Moderna, HSBC, Moderna, Google, YouTube, " Bank of America, Omega Healthcare, Sun, DuPont's Mobility, JPMorgan, Navy, Bentley Systems Locations: USD75, Asana, ASAN
Oppenheimer reiterates Apple as outperform Oppenheimer said it's bullish on Apple's future in gaming. Bank of America reiterates Alphabet as buy Bank of America raised its price target on the stock to $175 per share from $166. Bank of America reiterates Apple as buy Bank of America said it's standing by its buy rating Apple. Bank of America reiterates Amazon as buy Bank of America said Amazon is "well positioned." RBC downgrades Northrop Grumman to sector perform from outperform RBC downgraded the stock after its earnings earnings and says upside is limited.
Persons: Oppenheimer, it's, Tesla, TD Cowen, Needham, headwinds, JPMorgan downgrades Dow, Piper Sandler, Piper, UBS downgrades Archer, Daniels, Northrop, Goldman Sachs, Goldman, Jabil, Wedbush, Evercore Organizations: Seagate, Apple, Bank of America, JPMorgan, Airlines, American Airlines Group, UBS, Humana, Intel, SEC, Deutsche Bank, Deutsche, SNAP, Bancorp, Daniels Midland, Price Target, RBC Locations: Mexico
The biopharmaceutical sector is expected to offer a safe haven from macroeconomic and earnings concerns ahead of final quarterly results from companies, according to Morgan Stanley. Morgan Stanley, however, cautioned that the outlook for drug pricing reform in the U.S. poses risks for the sector. Shares of Indivior , argenx , AstraZeneca , Merck , Lonza, Sweden's Sobi, Novo Nordisk and Sandoz Group were among those listed by Morgan Stanley with a "buy" rating. In a bull case where Sublocade hits $2.2 billion in sales by 2030, Morgan Stanley sees shares rising further to 3,500 British pence. Novo Nordisk Shares of Novo Nordisk , a leader in diabetes and obesity drugs, offer a 9.4% upside, according to Morgan Stanley.
Persons: Morgan Stanley, Mark D Purcell, Sweden's, Sublocade, Thibault Boutherin, Morgan, — CNBC's Michael Bloom Organizations: Barclays, Bank of America, AstraZeneca, Merck, Lonza, Novo Nordisk, Sandoz Group, AstraZeneca AstraZeneca, British pharma, EU Locations: U.S, argenx, Novo, Indivior
Investment bank UBS recently rolled out a slew of stocks the firm says are its best ideas in 2024. CNBC Pro combed through UBS research to find stocks that are must-owns with 2024 underway. They include Target, Teck Resources , General Motors, Dell and CrowdStrike. Dell Dell shares are too cheap to ignore, according to analyst David Vogt, who named the stock his top pick for 2024 in a recent note. Dell "Dell as end mkt recovery & share repo should drive outperformance.
Persons: David Vogt, Vogt, Dell, Teck, Curt Woodworth, Woodworth, Michael Lasser, Lasser, Organizations: UBS, CNBC, Target, General Motors, Dell, Dell Dell, Teck Resources UBS, Teck Resources Locations: Teck Resources, Teck, CY24
Three stocks — Liberty Broadband , U.K.'s BT Group and JD Sports Fashion — have risen by double-digit percentages this year. Liberty Broadband Liberty Broadband is a telecommunication holding company that has an ownership interest in Charter Communications, the second-largest cable operator in the United States. The consensus price target of analysts polled by FactSet points to a 55% upside potential for Liberty Broadband shares from the current share price of $82. Deutsche Bank views Liberty Broadband as an attractive way to invest in Charter, estimating it trades at a 32% discount to net asset value (NAV). BT.A-GB YTD line Their price target of 220 pence implies an additional 79% share price increase over the next year from the current share price of 123 pence.
Persons: FactSet, Bryan Kraft, Benjamin Soff, Morgan Stanley, Openreach, Terence Tsui, Kate Calvert, Calvert, JD, Michael Bloom Organizations: Liberty Broadband, BT Group, JD, Wall, CNBC Pro, CNBC Pro Stock, Liberty Broadband Liberty Broadband, Charter Communications, Deutsche Bank, CHTR, BT, JD Sports, North America, Dick's Sporting Goods Locations: United States, Alaska, U.K, BT.A, Europe, North, Derby, Heerlen, Netherlands, U.S
Jefferies initiated Colgate-Palmolive with a buy rating, citing a stabilization in market share loss. The firm initiated coverage of DevOps stock on Monday with a buy rating and a $56 per share price target. "In short, we think GTLB is well positioned to gain share with its platform offering in a rapidly growing ~$40B DevSecOps target market," analyst Gray Powell said. The firm initiated coverage of the consumer giant with a buy rating and a $87 per share price target in a Sunday note. Analyst Kaumil Gajrawala said the company's market share losses from the height of the pandemic have stabilized, allowing Colgate-Palmolive to enter a period of steady growth.
Persons: Jefferies, Edward Jones, Oracle Edward Jones, Oracle's, Logan Purk, Purk, Brian Evans, Gray Powell, — Brian Evans, Bernstein, TripAdvisor, Richard Clarke, Asiya Merchant, Kaumil Gajrawala, Gajrawala Organizations: CNBC, Colgate, Palmolive, Citi, HP Inc, Oracle, Google, Amazon Web Services, Jefferies, ~$
UBS lowered its rating on Albemarle to neutral from buy, slashing its price target by more than 40%. Analyst Matthew Hedberg initiated coverage of the data stock at an outperform rating with a $22 target price for shares. Hedberg's price target implies shares could climb 23.9% over the next year from Friday's close. In addition to the downgrade, analyst Jessica Reif Ehrlich slashed her price target on the stock to $9 from $32. Analyst Joshua Spector downgraded the stock to neutral from buy and slashed his price target to $140 from $253.
Persons: Ferrari, Matthew Hedberg, Hedberg, Alex Harring, Jason Bazinet, Bazinet, — Alex Harring, Jefferies, Brent Thill, Thill, Jessica Reif Ehrlich, Reif, Vivek Arya, Arya, Nicholas Campanella, Campanella, " Campanella, Banks, Goldman Sachs, Citi's Paul Lejuez, Baird, Mark Altschwager, Morgan Stanley, Edouard Aubin, Aubin, there's, Henning Cosman, Cosman, Joshua Spector, Spector Organizations: CNBC, UBS, Barclays, Bank of America, Nvidia, RBC, RBC Capital Markets, Citi, Disney, Jefferies, Paramount, Paramount Global, Dominion Energy, Dominion, Wall, JPMorgan, Ferrari, U.S, UBS downgrades Locations: Albemarle, Friday's, China, Birkenstock
HSBC’s profit resilience may face sterner tests
  + stars: | 2023-10-30 | by ( Anshuman Daga | ) www.reuters.com   time to read: +4 min
SINGAPORE, Oct 30 (Reuters Breakingviews) - HSBC’s (HSBA.L), (0005.HK) resilient bottom line may face some stiffer challenges. HSBC also flagged that the same exercise would produce another $400 million loss in the final three months of the year. The bank’s net interest margin slipped to 1.7% in the latest quarter, from 1.72% in the previous three months. HSBC shares trade at around 0.9 times the bank’s tangible book value at the end of September. The bank’s London-listed shares were up 0.9% at 606 pence by 0900 GMT on Oct. 30.
Persons: It’s, Noel Quinn’s, Quinn, undemanding, it’s, Peter Thal Larsen, Oliver Taslic Organizations: Reuters, HK, Chartered, HSBC, Thomson Locations: SINGAPORE, China, London
Bank of America reiterates Meta as buy Bank of America said it's bullish heading into earnings next week. UBS upgrades Merck to buy from neutral UBS said Merck has an "undemanding" valuation and robust pipeline. UBS reiterates Ralph Lauren as buy UBS said the stock is best positioned for AI. UBS reiterates McDonald's as buy UBS said the stock remains attractively valued. Bank of America reiterates IBM as buy Bank of America said it's standing by its buy rating heading into earnings next week.
Persons: JPMorgan, Jefferies, Goldman Sachs, Goldman, it's, Merck, Stephens, Ralph Lauren, McDonald's, Cognizant, TSMC, Deutsch, Redburn, Raymond James Organizations: JPMorgan, Nvidia, Disney, Bank of America, Meta, UBS, Merck, Deutsche Bank, Union Pacific, Deutsche, IBM, Citi, Taiwan Semiconductor, Management, Deutsche Bank downgrades, Microsoft, Brands, Mattel, Disney Princess, of America Locations: China
A Siemens Gamesa blade factory on the banks of the River Humber in Hull, England on October 11, 2021. Siemens Energy made the headlines earlier this year when it scrapped its profit forecast and warned that costly failures at wind turbine subsidiary Siemens Gamesa could drag on for years. It sparked concerns about wider problems across the industry and thrust Europe's wind energy giants' earnings into the spotlight. Read more:Deutsche had previously highlighted challenges in the wind turbine industry including supplier delays, lower tax credits and rising rates. Reliability issues Those surveyed by ONYX also expressed reliability concerns, with 69% expecting more reliability issues due to aging assets and 56% seeing problems associated with new turbine technology.
Persons: PAUL ELLIS, Kepler Cheuvreux, Morgan Stanley, Morgan, Ben Uglow, Ørsted, Read, , Ashley Crowther, Crowther Organizations: Siemens, AFP, Getty, Siemens Energy, Grid Technologies, Siemens Gamesa, Gas, Grid, Deutsche Bank, Deutsche, Vestas, ONYX Locations: Hull , England, Ukraine
AdvertisementAdvertisementThe stock market is poised to disappoint investors over the coming months and into next year because S&P 500 earnings growth estimates are too optimistic, according to JPMorgan's quant guru Marko Kolanovic. Wall Street consensus expects S&P 500 earnings per share to deliver 4% year-over-year growth in the third-quarter, according to the note. Kolanovic doesn't expect much to change in 2024, arguing that Wall Street analysts are still too optimistic about the potential for earnings growth. Consensus estimates suggests that the S&P 500 will grow its earnings per share by 12% next year. Kolanovic is sticking by his year-end S&P 500 price target of 4,200, pointing to potential downside of 4% from current levels.
Persons: JPMorgan's, Marko Kolanovic, Kolanovic, Organizations: Service, PMI, Federal Reserve
UBS upgrades UnitedHealth to buy from neutral UBS called the stock a "core holding." Jefferies upgrades Pfizer to buy from hold Jefferies said investors should buy the dip in shares of Pfizer. UBS initiates Evolent Health as buy UBS said it sees more upside for the health-care company. Morgan Stanley upgrades Varonis Systems to overweight from equal weight Morgan Stanley said the data security and analytics company has "underappreciated AI tailwinds." UBS upgrades Tal Education to buy from neutral UBS said a turnaround for the education tech company is underway.
Persons: Morgan Stanley, Apple, Jefferies, Goldman Sachs, Horton, Piper Sandler, Tesla, Truist, Stifel Organizations: Apple, JPMorgan, Nvidia, NVIDIA, UBS, UNH, Jefferies, Pfizer, Maplebear Inc, Disney, US Parks, Evolent Health, payors, Varonis, Nice Systems, NICE, Netflix, ISI, Tal Education, RBC, BMO, Energy, Colgate, Palmolive Locations: UNH, U.S
With the stock market deeply oversold this week, we put cash to work by picking stocks across a range of sectors including energy, technology and materials. With the market oversold, per the S & P 500 Short Range Oscillator , our investment discipline called for us to search for any dislocations within the portfolio. Tech stocks remained under pressure Tuesday afternoon, giving us an opportunity to buy 7 shares of Broadcom and lower our cost basis. But stocks returned to the red Thursday, and the market remained firmly in oversold territory. However, the market reversed course in midday trading, with all three major U.S. stock benchmarks trading sharply higher.
Persons: chipmaker, we've, , Corona –, Jim, Elliott, We'd, Jim Cramer's, Jim Cramer, Spencer Platt Organizations: Coterra Energy, Devices, Broadcom, Starbucks, AMD, Tech, VMWare, Management, Wall, DuPont de Nemours, Oracle, Constellation Brands, DuPont, Modelo, Corona, Constellation, Elliott Management, U.S . Labor Department, Humana, CNBC, New York Stock Exchange, Getty Locations: China, oversold, ORCL, New York City
Here are Tuesday's biggest calls on Wall Street: KeyBanc reiterates Nvidia as overweight KeyBanc raised its price target on Nvidia to $750 per share from $670 and said it sees "outsized growth." Bank of America adds FedEx to the US1 list Bank of America added the stock to its top picks list. "Upgrading Clean Energy Fuels (CLNE) from Outperform to Strong Buy, with the company on the cusp of ramping up in-house RNG production." JPMorgan reiterates Amazon as a top pick JPMorgan said ignore the noise and buy the dip in shares of Amazon. Bank of America initiates Dycom as buy Bank of America said in its initiation of the telecommunications infrastructure company that it's uniquely positioned.
Persons: KeyBanc, Ally, Evercore, bode, Stifel, Churchill, CHDN, Raymond James, Baird, Vestis, Piper Sandler, Tesla, IBKR, Morgan Stanley, Rivian, it's, Warby Parker, Booz Allen Hamilton, Goldman Sachs, Wedbush Organizations: Nvidia, Aclaris Therapeutics, ISI, Citi, Arista Networks, Arista, " Bank of America, FedEx, Bank of America, FedEx Corp, Owl Capital, Swift Transportation, Evercore ISI, TAM, Energy Fuels, JPMorgan, FTC, DOJ, HP Inc, underperform Bank of America, HPQ, UBS, Booz, of America, Emerson Electric, Warner Music Group, Apple, Constellation Brands Locations: China, CY23
European value stocks are doing better than growth stocks right now, according to Citi analysts. Citi defined "quality" value stocks as those in the top fifth and fourth quintiles for three characteristics: value, low risk and quality. Citi said investors "have not been particularly risk-averse," as risky value stocks are up 8.6%, while quality value stocks are down 0.3% in the year to date. Nevertheless, the bank noted that investors appear to have been more cautious since the start of August, as quality value stocks are up 4.6%, while risky value stocks are down 0.6%. 'Risky value' stocks For this screen, Citi looked for stocks that scored in the seventh or above decile for value and those in the fifth or below decile for "value low risk" and quality.
Persons: TotalEnergies, Moller Maersk, — CNBC's Michael Bloom Organizations: Citi, HSBC Holdings, Zurich Insurance Group, ABN AMRO, Imperial Brands, Nokia, BNP, BMW, Bayer, Life, WPP PLC Locations: European, China, Dutch, Danish
Organon is an undervalued global play and leader in women's specialty health, according to Barclays. The company, with a portfolio of about 60 treatments and products focused on women's health, was spun off from Merck in 2021 . Barclays analyst Balaji Prasad initiated coverage on Organon with an overweight rating. The company could also generate more than $1 billion in annual free cash flow during that span, he added. Organon's prescription birth control Nexplanon is the key driver to its women's health portfolio as the Nexplanon "pipeline continues to progress toward commercialization," he added.
Persons: Balaji Prasad, Prasad, Nexplanon, — CNBC's Michael Bloom Organizations: Barclays, Merck, Health Locations: Wednesday's
Klaviyo — Klaviyo shares jumped more than 9% after the marketing automation company surged to $36.75 after its New York Stock Exchange initial public offering. Stellantis — Shares rose about 1.7% after sales in Europe of brands such as Peugeot and Opel surged more than 6% in August. On Holding — The shoe stock rose finished lower ever after Needham initiated coverage with a buy rating. Lululemon — The athleisure clothing company rose nearly 2% after Needham initiated coverage with a buy rating, saying it expects double-digit top-line growth as accelerating technical innovation drives demand. Davidson initiated coverage on the stock at a buy.
Persons: Instacart, Steelcase, Jefferies, Davidson, Mills, Coty, Morgan Stanley, Chewy, Oppenheimer, Needham, Goldman Sachs, Azul, it's, , Alex Harring, Hakyung Kim, Jesse Pound, Michelle Fox, Sarah Min, Yun Li, Lisa Kailai Han Organizations: Nasdaq, New York Stock Exchange, Bausch Health, , Health, Peugeot, Opel, Chrysler, United Auto Workers, Citi, D.A, LSEG, Coty, Technologies, Textron — Textron, Berkshire Hathaway, Cessna Citation, Azul, JPMorgan, First, Bank Locations: Europe, U.S
Total: 25